Related references
Note: Only part of the references are listed.New landscapes and horizons in hepatocellular carcinoma therapy
Melchiorre Cervello et al.
AGING-US (2020)
Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion
Yuanyuan Jiang et al.
CANCER LETTERS (2020)
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study
Laura Ridolfi et al.
JOURNAL OF GERIATRIC ONCOLOGY (2020)
Tumor Cell-Intrinsic USP22 Suppresses Antitumor Immunity in Pancreatic Cancer
Jinyang Li et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Low CD8+ T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44+/CD133+ Cancer Stem Cells and Predict an Unfavorable Prognosis in Pancreatic Cancer
Ya-Chin Hou et al.
CANCERS (2019)
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy
Rama Soundararajan et al.
CANCERS (2019)
Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma
Nitish Kumar Mishra et al.
FRONTIERS IN GENETICS (2019)
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Yaojie Fu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
Vinod P. Balachandran et al.
GASTROENTEROLOGY (2019)
Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
Maartje G. Schouwenburg et al.
CANCERS (2019)
Kras and Tumor Immunity: Friend or Foe?
Jane Cullis et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
S100A10, a novel biomarker in pancreatic ductal adenocarcinoma
Moamen Bydoun et al.
MOLECULAR ONCOLOGY (2018)
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson et al.
CANCER CELL (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (vol 165, pg 35, 2016)
Willy Hugo et al.
CELL (2017)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang et al.
NATURE MEDICINE (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation
Ching-Yi Liu et al.
ONCOTARGET (2015)
S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase
Pulin Che et al.
SCIENTIFIC REPORTS (2015)
Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity
Ingunn M. Stromnes et al.
GUT (2014)
USP22 promotes epithelial-mesenchymal transition via the FAK pathway in pancreatic cancer cells
Zhen Ning et al.
ONCOLOGY REPORTS (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
The ConsensusPathDB interaction database: 2013 update
Atanas Kamburov et al.
NUCLEIC ACIDS RESEARCH (2013)
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
Lauren J. Bayne et al.
CANCER CELL (2012)
Expression of S100A2 Calcium-Binding Protein Predicts Response to Pancreatectomy for Pancreatic Cancer
Andrew V. Biankin et al.
GASTROENTEROLOGY (2009)
Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis
K. Ohuchida et al.
JOURNAL OF PATHOLOGY (2007)
S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer
Patrick C. Mahon et al.
CANCER RESEARCH (2007)
The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target
K Ohuchida et al.
CLINICAL CANCER RESEARCH (2005)
Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation
Hirozumi Sawai et al.
MOLECULAR CANCER (2005)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
